University of Hawaii Cancer Center

New Discovery: How and Why BAP1 Mutation Increases Susceptibility to Environmental Carcinogens

Michele Carbone, MD, PhD, Director of Thoracic Oncology at the University of Hawaii (UH) Cancer Center, along with his team, have discovered why people carrying mutations of the BAP1 gene are more susceptible to environmental carcinogens, including asbestos, radiation, and ultraviolet light.
BAP1 mutations are seen in approximately 20 percent of all cancers, and Dr. Carbone […]


Meso Foundation Participates in 2015 Weinman Symposium

Mary Hesdorffer, APRN, the executive director of the Mesothelioma Applied Research Foundation, was one of the 30 international speakers at the 2015 Weinman Symposium at the University of Hawaii Cancer Center.
The conference, which was sponsored by Weinman Foundation’s Honolulu chapter, the National Cancer Institute, National Institute of Environmental Health Sciences, International Association for the Study […]


Mesothelioma Researcher Receives Pioneer Award

The Mesothelioma Applied Research Foundation announced today that the 2014 recipient of its Pioneer Award is Michele Carbone, MD, PhD, for his remarkable achievements in mesothelioma research.
Michele Carbone, MD, PhD is a Professor of Pathology and the Director of the University of Hawaii Cancer Center, a National Cancer Institute designated Consortium Cancer Center affiliated with […]